|
MON2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.275000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.700170E-01 |
| Normal-vs-Stage2 |
3.024200E-01 |
| Normal-vs-Stage3 |
7.439400E-01 |
| Normal-vs-Stage4 |
6.538200E-01 |
| Stage1-vs-Stage2 |
7.823200E-01 |
| Stage1-vs-Stage3 |
3.641400E-01 |
| Stage1-vs-Stage4 |
1.112380E-01 |
| Stage2-vs-Stage3 |
3.937400E-01 |
| Stage2-vs-Stage4 |
1.982850E-01 |
| Stage3-vs-Stage4 |
4.804400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.410200E-01 |
| Normal-vs-AfricanAmerican |
9.897800E-01 |
| Normal-vs-Asian |
1.702190E-01 |
| Caucasian-vs-AfricanAmerican |
5.437200E-01 |
| Caucasian-vs-Asian |
4.479400E-01 |
| AfricanAmerican-vs-Asian |
3.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.743200E-01 |
| Normal-vs-Female |
1.560250E-01 |
| Male-vs-Female |
2.775800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.335210E-01 |
| Normal-vs-Age(41-60Yrs) |
6.266100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.188200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.077400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.163800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.632160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.033600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.078200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.816400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.173400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.402300E-03 |
| Normal-vs-Grade 2 |
1.791560E-02 |
| Normal-vs-Grade 3 |
9.451600E-01 |
| Normal-vs-Grade 4 |
1.913800E-02 |
| Grade 1-vs-Grade 2 |
2.691800E-01 |
| Grade 1-vs-Grade 3 |
1.172090E-02 |
| Grade 1-vs-Grade 4 |
3.990200E-04 |
| Grade 2-vs-Grade 3 |
7.839800E-03 |
| Grade 2-vs-Grade 4 |
3.61189999997791E-06 |
| Grade 3-vs-Grade 4 |
7.919900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.770300E-04 |
| Normal-vs-ccB subtype |
3.265600E-01 |
| ccA subtype-vs-ccB subtype |
2.65680000000046E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.492230E-01 |
| Normal-vs-N1 |
1.715360E-01 |
| N0-vs-N1 |
1.165560E-01 |
|
|
